February 1, 2024

Neolight Secures GPO Contract with Capstone Health Alliance for Skylife Neonatal Phototherapy System

Revolutionary Skylife System Gains Wider Reach with Capstone Deal, Bringing Faster Bilirubin Reduction and Improved Care Experience
Geometric shape

Scottsdale, AZ, February 1, 2024– Neolight, a leading developer of innovative medical devices for newborns, today announced it has secured a new Group Purchasing Organization (GPO) contract with Capstone Health Alliance, a leading regional GPO serving hundreds of hospitals and thousands of health care providers nationwide.

This agreement grants Capstone members access to Neolight's revolutionary Skylife Neonatal Phototherapy System, designed to optimize bilirubin reduction in jaundiced newborns while enhancing clinical workflow and patient experience.

"We are excited to partner with Capstone Health Alliance and make the Skylife System even more accessible to hospitals across the country," said Vivek Kopparthi, NeoLight Co-founder and CEO, "Capstone's commitment to improving healthcare quality and reducing costs aligns perfectly with our mission to revolutionize neonatal care."

MaryBeth Smith, NeoLight’s Chief Commercial Officer, added: "This partnership with Capstone is a significant step forward in our mission to provide more babies with the best possible start in life. The Skylife System has been proven to reduce bilirubin levels faster and more effectively than traditional phototherapy methods, while also improving the care experience for both babies and their families."

Key Benefits of the Skylife Neonatal Phototherapy System:

·      Best-in-Class Spectral Power: Exceeds AAP guidelines for faster, more effective treatment.

·      Reduced Bedside Equipment: Compact design minimizes space requirements.

·      Enhanced Nurse Workflow: Streamlined operation frees up valuable time for caregivers.

·      Promotes Family Bonding: Enables intermittent therapy for kangaroo care and skin-to-skin contact.

·      40% Body Surface Coverage: Delivers uniform, effective light therapy.

·      Three Irradiance Levels: Offers optimal control for various clinical needs.

NeoLight is a medical device company that develops empathy driven, best-in-class technologies for treating preventable conditions in the newborn care market. Empathy driven solutions are a framework that has the doctor-nurse-mother-infant ecosystem at the center. It fosters the emotional connection that happens, thereby providing not just treatment but also providing care. Driving neonatal care beyond the traditional hospital setting, NeoLight is also creating a robust home market to treat neonatal conditions in the home. To learn more, visit www.theneolight.com and follow us on Twitter and LinkedIn.